Sylwia Marciniec-Popek

Zamosc, LU, Poland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

Associations of ANGPT2 expression and its variants (rs1868554 and rs7825407) with multiple myeloma risk and outcome.

Associations of ANGPT2 expression and its variants (rs1868554 and rs7825407) with multiple myeloma risk and outcome.

Journal: Frontiers in oncology
Published: July 21, 2024

In Vitro Low-Bortezomib Doses Induce Apoptosis and Independently Decrease the Activities of Glutathione S-Transferase and Glutathione Peroxidase in Multiple Myeloma, Taking into Account the GSTT1 and GSTM1 Gene Variants.

In Vitro Low-Bortezomib Doses Induce Apoptosis and Independently Decrease the Activities of Glutathione S-Transferase and Glutathione Peroxidase in Multiple Myeloma, Taking into Account the GSTT1 and GSTM1 Gene Variants.

Journal: Genes
Published: February 17, 2024

Association of Chromosome 17 Aneuploidy, TP53 Deletion, Expression and Its rs1042522 Variant with Multiple Myeloma Risk and Response to Thalidomide/Bortezomib Treatment.

Association of Chromosome 17 Aneuploidy, TP53 Deletion, Expression and Its rs1042522 Variant with Multiple Myeloma Risk and Response to Thalidomide/Bortezomib Treatment.

Journal: Cancers
Published: August 23, 2023

The Relationship of CCL5 and CCR1 Variants with Response Rate and Survival Taking into Account Thalidomide/Bortezomib Treatment in Patients with Multiple Myeloma.

The Relationship of CCL5 and CCR1 Variants with Response Rate and Survival Taking into Account Thalidomide/Bortezomib Treatment in Patients with Multiple Myeloma.

Journal: Journal of clinical medicine
Published: February 10, 2023

The Effects of Genistein at Different Concentrations on MCF-7 Breast Cancer Cells and BJ Dermal Fibroblasts.

The Effects of Genistein at Different Concentrations on MCF-7 Breast Cancer Cells and BJ Dermal Fibroblasts.

Journal: International journal of molecular sciences
Published: August 31, 2022

WT1 Gene Mutations, rs16754 Variant, and WT1 Overexpression as Prognostic Factors in Acute Myeloid Leukemia Patients.

WT1 Gene Mutations, rs16754 Variant, and WT1 Overexpression as Prognostic Factors in Acute Myeloid Leukemia Patients.

Journal: Journal of clinical medicine
Published: February 19, 2022

The Relationship of ABCB1/MDR1 and CYP1A1 Variants with the Risk of Disease Development and Shortening of Overall Survival in Patients with Multiple Myeloma.

The Relationship of ABCB1/MDR1 and CYP1A1 Variants with the Risk of Disease Development and Shortening of Overall Survival in Patients with Multiple Myeloma.

Journal: Journal of clinical medicine
Published: October 07, 2021

CCL3 as Possible Negative Prognostic Factor in Chronic Lymphocytic Leukemia.

CCL3 as Possible Negative Prognostic Factor in Chronic Lymphocytic Leukemia.

Journal: Acta haematologica
Published: September 07, 2021

Pain incidence in cervical dystonia is determined by the disease phenotype.

Pain incidence in cervical dystonia is determined by the disease phenotype.

Journal: Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia
Published: May 01, 2020

The Impact of the NOD2/CARD15 Variant (3020insC) and PSMA6 Polymorphism (-8C>G) on the Development and Outcome of Multiple Myeloma.

The Impact of the NOD2/CARD15 Variant (3020insC) and PSMA6 Polymorphism (-8C>G) on the Development and Outcome of Multiple Myeloma.

Journal: BioMed research international
Published: March 27, 2020

Examination of clonal evolution in chronic lymphocytic leukemia.

Examination of clonal evolution in chronic lymphocytic leukemia.

Journal: Medical oncology (Northwood, London, England)
Published: May 30, 2019

The Association of GSTT1, GSTM1, and TNF-α Polymorphisms With the Risk and Outcome in Multiple Myeloma.

The Association of GSTT1, GSTM1, and TNF-α Polymorphisms With the Risk and Outcome in Multiple Myeloma.

Journal: Frontiers in oncology
Published: April 03, 2019
Showing 1-12 of 15

Last Updated: 09/26/2026